Sanderling Ventures Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 7
- Investments
- 157
- Portfolio
- 18
- Exits
- 63
Sanderling Ventures General Information
Description
Sanderling Ventures is a venture capital firm that was founded in 1979 and is based in San Mateo, California. The firm prefers to invest in the biotechnology, life sciences, therapeutics and pharmaceuticals, drug delivery, medical devices and instrumentation, diagnostics, medical informatics, healthcare information technology and health care services sectors.
Contact Information
Website
Year Founded
1979
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Limited Partner
Primary Office
- 400 South El Camino Real
- Suite 1200
- San Mateo, CA 94402
- United States
+1 (650) 000-0000
Sanderling Ventures Investments (157)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ViaCyte | 26-May-2020 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - General | 0000 000000000 |
| 00000000000 | 22-May-2020 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - General | 000000 000000 00.0 |
| 000000000 | 07-Aug-2019 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | 0000000 00000 |
| 00000 000000000000 | 10-May-2019 | 0000 00000 | Biotechnology | Product Development | 000000 000000 00.0 | |
| 00000000000 | 15-Dec-2017 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | 0000000 00000 |
| 0000000000 000000 | 23-Aug-2017 | 0000 00000 | 000 | Biotechnology | Startup | |
| 0000000000 | 27-Jul-2017 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000 0000000000 00.0 |
| 000000 00000000 | 17-Jul-2017 | 00000 00000 | 000.00 | Monitoring Equipment | Generating Revenue/Not Profitable | 000000 000000 00.0 |
| PreciThera | 10-May-2017 | Seed Round | Biotechnology | Generating Revenue | 000000 00000000000 00.0 | |
| Glycomine | 16-Nov-2016 | Early Stage VC | 0000 | Drug Discovery | Clinical Trials - General | 00000 0000000000 00.0 |
Sanderling Ventures Exits (63)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Lineagen | 24-Aug-2020 | Merger/Acquisition | 0000 |
| 000000 00000000000 | 01-Nov-2017 | 000 00 00000000 | |
| 00000 0000000000 | 01-Aug-2017 | 000000000000000000 | 000 |
| 00000000 | 01-Jun-2017 | 0000000000: 000000 | |
| 00000 0000000 | 23-Mar-2017 | 000000000000000000 | |
| 000000 00000000 | 08-Dec-2016 | 000000000000000000 | |
| 00000000 | 01-Dec-2016 | 000 00 00000000 | |
| 000000 00000000 | 07-Oct-2016 | 0000000000: 000000 | |
| Skyepharma | 10-Jun-2016 | Merger/Acquisition | 00000 |
| Infraredx | 31-Oct-2015 | Merger/Acquisition | 0000 |
Sanderling Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Sanderling Ventures‘s full profile, request access.
Request a free trialSanderling Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialSanderling Ventures Team (22)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Timothy Wollaeger | Managing Director Emeritus | 00 | 0 | 0 | San Mateo, CA |
| Norman Marcus MD | Venture Partner | San Diego, CA | |||
| Benjamin McGraw III | Venture Partner | 0 | San Mateo, CA | ||
| Paulette Taylor JD | General Counsel & Principal | 0 | 0 | San Mateo, CA | |
| Robert Mcneil Ph.D | Founder & Managing Director | 00 | 0 | 0 | San Mateo, CA |
Sanderling Ventures Co-Investors (24)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Bain Capital | 1 | 0 |
|
|
|
| GeneChem | 0 | 0 |
|
|
|
| New Enterprise Associates | 0 | 0 |
|
|
|
| Novo Holdings | 0 | 0 |
|
|
|
| Versant Venture | 0 | 0 |
|
|